deltatrials
Completed NA INTERVENTIONAL 2-arm NCT05584176

COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation

Over the Counter Rapid Antigen Test for Detection of SARS-CoV-2 Virus: Clinical Evaluation

Sponsor: MP Biomedicals, LLC

Updated 6 times since 2022 Last updated: May 4, 2023 Started: Dec 9, 2021 Primary completion: Jan 21, 2022 Completion: Jan 21, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates COVID-19 and SARS-CoV2 Infection and is currently completed. MP Biomedicals, LLC leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Nov 2022 – ~Jul 2023 · 8 months · monthly snapshotCompleted~Jul 2023 – ~Dec 2023 · 5 months · monthly snapshotCompleted~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Dec 2023 — Jul 2024 [monthly]

    Completed NA

  5. Jul 2023 — Dec 2023 [monthly]

    Completed NA

Show 1 earlier version
  1. Nov 2022 — Jul 2023 [monthly]

    Completed NA

    First recorded

Dec 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • MP Biomedicals, LLC
  • New Day Diagnostics
Data source: MP Biomedicals, LLC

For direct contact, visit the study record on ClinicalTrials.gov .